Evidence map›Paper›PMID 25299700›Full record

ArticlePLoS genetics2014

Dominant sequences of human major histocompatibility complex conserved extended haplotypes from HLA-DQA2 to DAXX.

Charles E Larsen, Dennis R Alford, Michael R Trautwein, Yanoh K Jalloh, Jennifer L Tarnacki, Sushruta K Kunnenkeri, Dolores A Fici, Edmond J Yunis, Zuheir L Awdeh, Chester A Alper

Abstract read
In one paragraph

Article in PLoS genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Sequences of 95 humanGenome research · 2017
    Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Charles E LarsenProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, Massachusetts, United States of America; Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America.
Dennis R AlfordProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, Massachusetts, United States of America.
Michael R TrautweinProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, Massachusetts, United States of America.
Yanoh K JallohProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, Massachusetts, United States of America.
Jennifer L TarnackiProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, Massachusetts, United States of America.
Sushruta K KunnenkeriProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, Massachusetts, United States of America.
Dolores A FiciProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, Massachusetts, United States of America; Pulsar Clinical Technologies, Cambridge, Massachusetts, United States of America.
Edmond J YunisDepartment of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America; Department of Pathology, Harvard Medical School, Boston, Massachusetts, United States of America.
Zuheir L AwdehProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, Massachusetts, United States of America; Pulsar Clinical Technologies, Cambridge, Massachusetts, United States of America.
Chester A AlperProgram in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, Massachusetts, United States of America; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, United States of America.

Funding

STUDIES OF NK AND T CELLS IN RELATION TO THE MAJOR HISTOCOMPATIBILITY COMPLEXP01HL029583 · NHLBI · IMMUNE DISEASE INSTITUTE, INC. · PI LARSEN, CHARLES E · 1985 to 2005
$9.8M
NHLBI NIH HHS HL-29583NHLBI NIH HHS P01 HL029583
6 · The paper itself

Abstract

We resequenced and phased 27 kb of DNA within 580 kb of the MHC class II region in 158 population chromosomes, most of which were conserved extended haplotypes (CEHs) of European descent or contained their centromeric fragments. We determined the single nucleotide polymorphism and deletion-insertion polymorphism alleles of the dominant sequences from HLA-DQA2 to DAXX for these CEHs. Nine of 13 CEHs remained sufficiently intact to possess a dominant sequence extending at least to DAXX, 230 kb centromeric to HLA-DPB1. We identified the regions centromeric to HLA-DQB1 within which single instances of eight "common" European MHC haplotypes previously sequenced by the MHC Haplotype Project (MHP) were representative of those dominant CEH sequences. Only two MHP haplotypes had a dominant CEH sequence throughout the centromeric and extended class II region and one MHP haplotype did not represent a known European CEH anywhere in the region. We identified the centromeric recombination transition points of other MHP sequences from CEH representation to non-representation. Several CEH pairs or groups shared sequence identity in small blocks but had significantly different (although still conserved for each separate CEH) sequences in surrounding regions. These patterns partly explain strong calculated linkage disequilibrium over only short (tens to hundreds of kilobases) distances in the context of a finite number of observed megabase-length CEHs comprising half a population's haplotypes. Our results provide a clearer picture of European CEH class II allelic structure and population haplotype architecture, improved regional CEH markers, and raise questions concerning regional recombination hotspots.

Indexed as

HaplotypesAdaptor Proteins, Signal TransducingBase SequenceChromosomes, Human, Pair 6Conserved SequenceCo-Repressor ProteinsGenes, DominantHLA-DP beta-ChainsHLA-DQ AntigensHLA-DQ beta-ChainsHumansLinkage DisequilibriumMajor Histocompatibility ComplexMolecular ChaperonesMutationNuclear ProteinsAdaptor Proteins, Signal TransducingCo-Repressor ProteinsDAXX protein, humanHLA-DPB1 antigenHLA-DP beta-ChainsHLA-DQA2 antigenHLA-DQ AntigensHLA-DQB1 antigenHLA-DQ beta-ChainsMolecular ChaperonesNuclear Proteins

Identifiers

PMID25299700
PMCPMC4191933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.